Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Primary Immunodeficiency Diseases in Northern Iran Publisher Pubmed



Mohammadzadeh I1, 2 ; Moazzami B1, 2 ; Ghaffari J3 ; Aghamohammadi A4, 5 ; Rezaei N4, 6, 7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Noncommunicable Pediatric Diseases Research Center, Babol University of Medical Sciences, Babol, Iran
  2. 2. Primary Immunodeficiency Diseases Network (PIDNet), Universal Scientific Education and Research Network (USERN), Babol, Iran
  3. 3. Department of Pediatrics, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
  4. 4. Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Primary Immunodeficiency Diseases Network (PIDNet), Universal Scientific Education and Research Network (USERN), Tehran, Iran
  6. 6. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  7. 7. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Boston, MA, United States

Source: Allergologia et Immunopathologia Published:2017


Abstract

Introduction Primary immunodeficiency diseases (PID) are a heterogeneous group of inherited disorders, characterised by recurrent severe infections, autoimmunity and lymphoproliferation. Despite impressive progress in identification of novel PID, there is an unfortunate lack of awareness among physicians in identification of patients with PID, especially in non-capital cities of countries worldwide. Result This study was performed in a single-centre paediatric hospital in Northern Iran during a 21-year period (1994–2015). Ninety-four patients were included in this study. The majority of cases had antibody deficiencies (37.23%), followed by well-defined syndromes with immunodeficiency in 16 (17.02%), phagocytic disorders in 15 patients (15.95%), complement deficiencies in 15 patients (15.95%), immunodeficiencies affecting cellular and humoral immunity in nine patients (9.57%), disease of immune dysregulation in three (3.19%), and defects in intrinsic and innate immunity in one (1.06%). Conclusion It seems that there are major variations in frequency of different types of PID in different regions of a country. Therefore, reporting local data could provide better ideas to improve the local health care system strategists and quality of care of PID patients. © 2017 SEICAP
Other Related Docs
12. Approach to the Management of Autoimmunity in Primary Immunodeficiency, Scandinavian Journal of Immunology (2017)
15. The Clinical and Immunological Features of Patients With Primary Antibody Deficiencies, Endocrine# Metabolic and Immune Disorders - Drug Targets (2018)
16. Severe Combined Immunodeficiency: A Case Series and Review From a Tertiary Pediatric Hospital, Iranian Journal of Allergy# Asthma and Immunology (2018)
17. Role of Apoptosis in the Pathogenesis of Common Variable Immunodeficiency (Cvid), Endocrine# Metabolic and Immune Disorders - Drug Targets (2017)
29. Infectious and Noninfectious Pulmonary Complications in Patients With Primary Immunodeficiency Disorders, Journal of Investigational Allergology and Clinical Immunology (2017)
35. Infectious Etiology of Chronic Diarrhea in Patients With Primary Immunodeficiency Diseases, European Annals of Allergy and Clinical Immunology (2019)
37. Inborn Errors of Immunity and Cancers, Cancer Immunology: A Translational Medicine Context# Second Edition (2020)
45. General Considerations, Pulmonary Manifestations of Primary Immunodeficiency Diseases (2018)
47. Investigating the Variation of Trec/Krec in Combined Immunodeficiencies, Iranian Journal of Allergy# Asthma and Immunology (2021)
48. Autoimmunity in Primary Antibody Deficiencies, International Archives of Allergy and Immunology (2017)